PRTA FY 2017 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$512M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$28M+2508.4% YoY

Gross Profit

-$107M-388.9% margin

Operating Income

-$155M-564.2% margin

Net Income

-$153M-556.8% margin

EPS (Diluted)

$-4.07

Cash Flow

Operating Cash Flow

-$131M

Free Cash Flow

-$135M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$496M

Total Liabilities

$89M

Stockholders' Equity

$407M

Cash & Equivalents

$418M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28M	$1M	+2508.4%
Gross Profit	-$107M	-$118M	+9.7%
Operating Income	-$155M	-$160M	+2.7%
Net Income	-$153M	-$160M	+4.3%